The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3Z)-1H-Indole-2,3-dione-3-{[3-(3-bromophenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]hydrazone} ID: ALA4279570
Chembl Id: CHEMBL4279570
PubChem CID: 145979412
Max Phase: Preclinical
Molecular Formula: C22H14BrN5O2
Molecular Weight: 460.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Nc2ccccc2/C1=N/Nc1nc2ccccc2c(=O)n1-c1cccc(Br)c1
Standard InChI: InChI=1S/C22H14BrN5O2/c23-13-6-5-7-14(12-13)28-21(30)16-9-2-4-11-18(16)25-22(28)27-26-19-15-8-1-3-10-17(15)24-20(19)29/h1-12H,(H,25,27)(H,24,26,29)
Standard InChI Key: AHRIIIZUGOVNIN-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 460.29Molecular Weight (Monoisotopic): 459.0331AlogP: 3.92#Rotatable Bonds: 3Polar Surface Area: 88.38Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.93CX Basic pKa: 2.54CX LogP: 4.62CX LogD: 4.62Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: -1.24
References 1. Kumari S, Chowdhury J, Sikka M, Verma P, Jha P, Mishra AK, Saluja D, Chopra M.. (2017) Identification of potent cholecystokinin-B receptor antagonists: synthesis, molecular modeling and anti-cancer activity against pancreatic cancer cells., 8 (7): [PMID:30108868 ] [10.1039/C7MD00171A ]